Funding, M&A and exec moves matched to your market — guaranteed to pay for itself in a year, or we refund it. See terms for full details.See plans →

API Holdings acquires control of Thyrocare

PRIVATEAug 17, 2026•about 3 hours ago

Acquiring Company

API Holdings

Acquired Company

Thyrocare Technologies

Mumbai

Navi MumbaiBiotechnologyHealth CarePharmaceuticalBiotechnologyHealth Care

Description

API Holdings, the parent company of PharmEasy, has acquired a controlling stake of 66.1% in Thyrocare Technologies. This strategic move was facilitated through Docon Technologies, its wholly-owned subsidiary. The acquisition represents a significant development in the healthcare sector, merging online pharmacy services with diagnostic capabilities. This endeavor aims to enhance service delivery and accessibility for consumers.

Company Information

Company

API Holdings

Location

Mumbai, Maharashtra, India

About

API Holdings, the parent company of PharmEasy, a prominent online pharmaceutical platform, has successfully raised $216 million in its latest funding round valuing the company at $710 million. Founded in 2015, the pharma-tech headquartered in Mumbai, specializes in providing convenient access to medicines and healthcare products through its online platform. With the infusion of fresh capital, API Holdings aims to address debt obligations and bolster its financial position. The funding will enable the company to navigate challenges and pursue strategic initiatives for further expansion and innovation in the healthcare sector.

Don't miss API Holdings's next move

Get an email the moment API Holdings makes an acquisition, hires an exec, or expands — usually minutes after it happens.

One email per event. Unsubscribe anytime.

Related People

Choose your plan to reveal verified contacts

Predictive Intelligence

Strategic

ML-powered predictions for API Holdings's next move

Learn about Strategic plan

M&A Insights

Based on deal data

Integration timeline

70% of M&A integrations take 12-24 months to complete

Tech stack consolidation

83% of merged companies consolidate technology vendors within first year

Post-acquisition investment

Companies increase IT spending by 23% on average after acquisitions

Success factor

M&A deals with strong technology integration plans are 2.5x more likely to succeed

Frequently asked

Who acquired Thyrocare Technologies?

Thyrocare Technologies was acquired by API Holdings, based in Mumbai. The deal was reported on August 17, 2026. API Holdings, the parent company of PharmEasy, a prominent online pharmaceutical platform, has successfully raised $216 million in its latest funding round valuing the company at $710 million. API Holdings is privately held and operates in Biotechnology.

When did API Holdings acquire Thyrocare Technologies?

API Holdings's acquisition of Thyrocare Technologies was reported on August 17, 2026. API Holdings, the parent company of PharmEasy, has acquired a controlling stake of 66.1% in Thyrocare Technologies. This strategic move was facilitated through Docon Technologies, its wholly-owned subsidiary. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Thyrocare Technologies do?

Thyrocare Technologies is a prominent diagnostics company in India. It focuses on expanding its operational footprint while ensuring high-quality diagnostic services. The company aims to provide reliable and affordable diagnostic solutions. It is privately held, operating in Biotechnology, and is based in Navi Mumbai.